Medicines in Development for Alzheimer's 2016 Report

Medicines in Development for Alzheimer's

PhRMA March 28, 2016

To download the full report, click here.

Today, more than 5 million Americans have Alzheimer’s disease. The disease devastates the minds of patients, creates substantial burdens for families and caregivers, and currently costs the health care system more than $200 billion a year. These sobering statistics are projected to get much worse as the 76 million American baby boomers age.

Medicines currently available for Alzheimer’s treat the cognitive symptoms of the disease — helping to address memory loss, confusion and problems with thinking — but do not afect the underlying causes of the disease.

Download Full Report